MAGE revisited: Evaluation of glucose variability with once daily glargine vs NPH insulin in type 2 diabetes

被引：0
|
作者：
Silvani, G. [1 ]
Acquati, S. [1 ]
Manini, R. [1 ]
Ragazzini, C. [1 ]
Taroni, S. [1 ]
Donadio, F. [1 ]
Buci, L. [1 ]
Gagliardi, L. [1 ]
Tartaglia, A. [1 ]
Nizzoli, M. [1 ]
机构：
[1] GB Morgagni L Pierantoni Hosp, Forli, Italy
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
978
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [22] Comparison of fasting capillary glucose variability between insulin glargine and NPH
    Mu, Panwei
    Lu, Hongyun
    Zhang, Guochao
    Chen, Yanming
    Fu, Jingyi
    Wang, Manman
    Shu, Jiong
    Zeng, Longyi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (01) : E4 - E7
  • [23] Concomitant use of insulin glargine and NPH in type I diabetes
    Khadilkar, VV
    Khadilkar, AV
    INDIAN PEDIATRICS, 2005, 42 (08) : 796 - 800
  • [24] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
    Dailey, G. E.
    Gao, L.
    Aurand, L.
    Garg, S. K.
    DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
  • [25] Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study
    H. Yki-Järvinen
    R. Kauppinen-Mäkelin
    M. Tiikkainen
    M. Vähätalo
    H. Virtamo
    K. Nikkilä
    T. Tulokas
    S. Hulme
    K. Hardy
    S. McNulty
    J. Hänninen
    H. Levänen
    S. Lahdenperä
    R. Lehtonen
    L. Ryysy
    Diabetologia, 2006, 49 : 442 - 451
  • [26] A three-month comparison between multiple daily NPH and once daily glargine insulin administration in intensive replacement of basal insulin in Type 1 diabetes mellitus.
    Rossetti, P
    Pampanelli, S
    Costa, E
    Torlone, E
    Brunetti, P
    Bolli, GB
    DIABETOLOGIA, 2002, 45 : A259 - A259
  • [27] Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
    Yki-Järvinen, H
    Kauppinen-Mäkelin, R
    Tiikkainen, M
    Vähätalo, M
    Virtamo, H
    Nikkilä, K
    Tulokas, T
    Hulme, S
    Hardy, K
    McNulty, S
    Hänninen, J
    Levänen, H
    Lahdenperä, S
    Lehtonen, R
    Ryysy, L
    DIABETOLOGIA, 2006, 49 (03) : 442 - 451
  • [28] Benefits of a fixed-ratio formulation of once-daily insulin glargine/lixisenatide (LixiLan) vs glargine in type 2 diabetes inadequately controlled on metformin
    Rosenstock, J.
    Diamant, M.
    Silvestre, L.
    Souhami, E.
    Zhou, T.
    Fonseca, V.
    DIABETOLOGIA, 2014, 57 : S108 - S108
  • [29] Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies
    Duckworth, William
    Davis, Stephen N.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 196 - 204
  • [30] Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus
    Gupta, K. S.
    Gupta, U.
    VALUE IN HEALTH, 2007, 10 (03) : A70 - A70
12345